Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Cancer epigenetics

Edelweiss: Cancer Open Access journal | Cancer epigenetics Research articles | Open access oncogenes Articles

Cancer epigenetics is the study of epigenetic modifications to the DNA of cancer cells that do not involve a change in the nucleotide sequence. Epigenetic alterations may be more important, than genetic mutations in a cells transformation to cancer. Manipulation of epigenetic alterations holds great promise for cancer prevention, detection, and therapy. In different types of cancer, a variety of epigenetic mechanisms can be perturbed, such as silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications, and dysregulation of DNA binding proteins. Several medications which have epigenetic impact are now used in several of these diseases.

Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Cancer epigenetics, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.

Related Articles

Related article links for Cancer epigenetics will appear here as matching content is published in Edelweiss: Cancer Open Access (ISSN: 2689-6737). Readers can also browse the journal archive and current issue for connected research.

More Topics in This Journal

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Subscribe for updates

Subscribe

to get latest updates.


  Life Science

  Health Science

  Chemical Science


Subscribe